Evidence map›Paper›PMID 35867142›Full record

ArticleWorld journal of urology2022

Comparison of perioperative outcomes following transperitoneal versus retroperitoneal robot-assisted partial nephrectomy: a propensity-matched analysis of VCQI database.

Gopal Sharma, Milap Shah, Puneet Ahluwalia, Prokar Dasgupta, Benjamin J Challacombe, Mahendra Bhandari, Rajesh Ahlawat, Sudhir Rawal, Nicolo M Buffi, Ananthkrishnan Sivaraman and 13 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Author Reply Re: Sharma G, Shah M, Ahluwalia P, Dasgupta P, Challacombe BJ, Bhandari M,Indian journal of urology : IJU : journal of the Urological Society of India
    Article
  16. Round up.Indian journal of urology : IJU : journal of the Urological Society of India
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 18 institutions in 9 countries.

Gopal SharmaDepartment of Urologic Oncology, Max Institute of Cancer Care, Saket, New Delhi, India.
Milap ShahDepartment of Urologic Oncology, Max Institute of Cancer Care, Saket, New Delhi, India.
Puneet AhluwaliaDepartment of Urologic Oncology, Max Institute of Cancer Care, Saket, New Delhi, India.
Prokar DasguptaKing's College, King's Health Partners, London, UK.
Benjamin J ChallacombeGuy's and St. Thomas' NHS Foundation Trust, London, UK.
Mahendra BhandariVattikuti Foundation, Detroit, MI, USA.
Rajesh AhlawatThe Medicity Hospital, New Delhi, India.
Sudhir RawalRajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
Nicolo M BuffiHumanitas Research Hospital, Rozzano, MI, Italy.
Ananthkrishnan SivaramanChennai Urology and Robotics Institute, Chennai, India.
James R PorterSwedish Medical Center, Seattle, WA, USA.
Craig RogersHenry Ford Hospital, Detroit, MI, USA.
Alexandre MottrieORSI Academy, Melle, Belgium.
Ronney AbazaCentral Ohio Urology Group, Mount Carmel Health System Prostate Cancer Program, Columbus, OH, USA.
Khoon Ho RhaYonsei University Health System, Seoul, South Korea.
Daniel MoonPeter MacCallum Hospital, University of Melbourne, Royal Melbourne Clinical School, Melbourne, Australia.
Thyavihally B YuvarajaKokilaben Dhirubhai Ambani Hospital, Mumbai, India.
Dipen J ParekhUniversity of Miami Health System, Miami, FL, USA.
Umberto CapitanioUrological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
Kris K MaesCenter for Robotic and Minimally Invasive Surgery, Hospital Da Luz, Luz Sáude, Portugal.
Francesco PorpigliaSan Luigi Gonzaga Hospital of Orbassano, Turin, Italy.
Levent TurkeriAcıbadem M.A., Department of Urology, Aydınlar University, Altuzinade Hospital, Istanbul, Turkey.
Gagan GautamDepartment of Urologic Oncology, Max Institute of Cancer Care, Saket, New Delhi, India. gagangg@gmail.com.ORCID http://orcid.org/0000-0002-3106-706X
Max Healthcare · INAcıbadem Adana Hospital · TRGuy's and St Thomas' NHS Foundation Trust · GBHenry Ford Hospital · USHospital da Luz · PTIRCCS Humanitas Research Hospital · ITIRCCS Ospedale San Raffaele · ITKings Health Partners · GBKokilaben Dhirubhai Ambani Hospital · INMedanta The Medicity · INMount Carmel Health · USORSI Academy · BEOspedale San Luigi Gonzaga · ITRajiv Gandhi Cancer Institute and Research Centre · INSwedish Medical Center · USThe University of Melbourne · AUUniversity of Miami Health System · USYonsei University Health System · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare perioperative outcomes following retroperitoneal robot-assisted partial nephrectomy (RPRAPN) and transperitoneal robot-assisted partial nephrectomy (TPRAPN).

methodsWith this Vattikuti Collective Quality Initiative (VCQI) database, study propensity scores were calculated according to the surgical access (TPRAPN and RPRAPN) for the following independent variables, i.e., age, sex, side of the surgery, RENAL nephrometry scores (RNS), estimated glomerular filtration rate (eGFR) and serum creatinine. The study's primary outcome was the comparison of trifecta between the two groups.

resultsIn this study, 309 patients who underwent RPRAPN were matched with 309 patients who underwent TPRAPN. The two groups matched well for age, sex, tumor side, polar location of the tumor, RNS, preoperative creatinine and eGFR. Operative time and warm ischemia time were significantly shorter with RPRAPN. Intraoperative blood loss and need for blood transfusion were lower with RPRAPN. There was a significantly higher number of intraoperative complications with RPRAPN. However, there was no difference in the two groups for postoperative complications. Trifecta outcomes were better with RPRAPN (70.2% vs. 53%, p < 0.0001) compared to TPRAPN. We noted no significant change in overall results when controlled for tumor location (anteriorly or posteriorly). The surgical approach, tumor size and RNS were identified as independent predictors of trifecta on multivariate analysis.

conclusionRPRAPN is associated with superior perioperative outcomes in well-selected patients compared to TPRAPN. However, the data for the retroperitoneal approach were contributed by a few centers with greater experience with this technique, thus limiting the generalizability of the results of this study.

Indexed as

Kidney NeoplasmsRoboticsRobotic Surgical ProceduresBlood TransfusionHumansNephrectomyRetrospective StudiesTreatment OutcomePartial nephrectomyPropensity matchingRAPNRetroperitoneal

Identifiers

PMID35867142
OpenAlexW4286488867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.